Excelerate Health Ventures

Excelerate Health Ventures is a venture capital firm based in Durham, North Carolina, that invests in seed and Series A companies developing B2B Pharma Tech and tech-enabled pharmaceutical services. The firm typically invests between $500,000 and $2 million in an initial round and often leads or co-leads, targeting capital-efficient companies rather than capital-intensive builds.

Its portfolio pattern is narrow by design. Excelerate concentrates on three overlapping domains - Pharma Tech, tech-enabled pharmaceutical services, and healthcare technology - serving the pharmaceutical, provider, and payer markets. The firm reports 19 investments to date and 8 strategic exits, a ratio consistent with a strategy oriented toward trade sales within the pharmaceutical and healthcare services sectors.

Support extends beyond capital. The firm provides hands-on operating assistance across customer introductions, go-to-market planning, hiring, financing, governance, and strategic partnerships. This is underpinned by an investor and advisor network spanning decision-makers at pharmaceutical companies, providers, and payers - relationships that may serve as customers or acquirers for portfolio companies.

Roles at the firm sit at the intersection of investment judgement and sector expertise in healthcare and pharmaceutical services, given the degree to which sourcing, diligence, and value creation depend on industry relationships and operating experience.